• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 22.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Mark Miller, UK

    Mark Miller, UK

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Bayley, Australia

    Bayley, Australia

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Denis Blais, Canada

    Denis Blais, Canada

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Timmy, Belgium

    Timmy, Belgium

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Ali Var, Turkey

    Ali Var, Turkey

  • Hollister

    Hollister
    hollister

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Bob Simonds, USA

    Bob Simonds, USA

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • John Sweeney, USA

    John Sweeney, USA

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login